Skip To Main Content
Tamra Sami on Muck Rack

Tamra Sami

Verified
Perth
As seen in: BioWorld, Clarivate, U.S. News and World Report, Endpoints News, BioPharma Dive, CenterWatch, BioCentury, MTPConnect
Science writer, editor, publication manager with product development, Asia and emerging markets expertise.

Get in touch with Tamra

Contact Tamra, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Immunobiota targets oral immune tolerance in type 1 diabetes

|
By Tamra Sami Verified
| BioWorld Verified
Newco news Immunobiota targets oral immune tolerance in type 1 diabetes Can a gut-targeted, oral metabolite therapy deliver disease modification in type 1 diabetes without the hospital burden and immunosuppression associated with antibody approaches? Melbourne, Australia-based Immunobiota Therapeutics Pty Ltd. believes it can.
Open in Who Shared Issue with article?

Epicrispr’s gene-silencing bet gains $90M boost

|
By Tamra Sami Verified
| BioWorld Verified
Epicrispr’s gene-silencing bet gains $90M boost Four years after launching with a vision of controlling gene expression without altering DNA, Epicrispr Biotechnologies Inc. has secured an oversubscribed $90 million series C round to advance EPI-321, its lead epigenetic therapy for facioscapulohumeral muscular dystrophy, into pivotal trials. BioWorld Financings Musculoskeletal Rare disease Gene therapy Series C U.S.
Open in Who Shared Issue with article?

Transthera wins NMPA nod for post-FGFR cholangiocarcinoma

|
By Tamra Sami Verified
| BioWorld Verified
Transthera wins NMPA nod for post-FGFR cholangiocarcinoma Transthera Sciences Inc. has won Chinese approval for Yochanra (tinengotinib) in FGFR2-positive cholangiocarcinoma that has progressed after FGFR inhibitor therapy, potentially creating a new option for patients who have exhausted the targeted treatments that reshaped care for the molecularly defined cancer. BioWorld Asia Regulatory Cancer Small molecule Asia-Pacific China NMPA
Open in Who Shared Issue with article?
See all 1,841 articles